L-DOPA Is an Endogenous Ligand for OA1

Por Lopez, Vanessa M, Decatur, Christina L, Stamer, W. Daniel, Lynch, Ronald M, McKay, Brian S
Publicado em 2008

PieParty: visualizing cells from scRNA-seq data as pie charts

Por Kurtenbach, Stefan, Dollar, James J, Cruz, Anthony M, Durante, Michael A, Decatur, Christina L, Harbour, J William
Publicado no Life Sci Alliance (2021)

Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment

Por Houston, Samuel K, Shah, Nisha V, Decatur, Christina, Lonngi, Marcela, Feuer, William, Markoe, Arnold M, Murray, Timothy G
Publicado em 2013

Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes

Por Decatur, Christina L., Ong, Erin, Garg, Nisha, Anbunathan, Hima, Bowcock, Anne M., Field, Matthew G., Harbour, J. William
Publicado no JAMA Ophthalmol (2016)

Impact of Genetic Ancestry on Prognostic Biomarkers in Uveal Melanoma

Por Rodriguez, Daniel A., Sanchez, Margaret I., Decatur, Christina L., Correa, Zelia M., Martin, Eden R., Harbour, J. William
Publicado no Cancers (Basel) (2020)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma

Por Lonngi, Marcela, Houston, Samuel K, Murray, Timothy G, Sisk, Robert A, Decatur, Christina L, Cavalcante, Milena, Markoe, Arnold M
Publicado em 2013

Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma

Por Cai, Louis, Paez-Escamilla, Manuel, Walter, Scott D., Tarlan, Bercin, Decatur, Christina L., Perez, Barbara M., Harbour, J. William
Publicado no Am J Ophthalmol (2018)

Intraocular Dissemination of Uveal Melanoma Cells Following Radiotherapy: Evolving Management Over the Past Decade

Por Paez-Escamilla, Manuel, Walter, Scott D., Mohsenin, Amir, Decatur, Christina L., Harocopos, George J., Dubovy, Sander, Harbour, J. William
Publicado no Ophthalmic Surg Lasers Imaging Retina (2019)

Genomic evolution of uveal melanoma arising in ocular melanocytosis

Por Durante, Michael A., Field, Matthew G., Sanchez, Margaret I., Covington, Kyle R., Decatur, Christina L., Dubovy, Sander R., Harbour, J. William
Publicado no Cold Spring Harb Mol Case Stud (2019)

2-DEOXY-GLUCOSE DOWN REGULATES ENDOTHELIAL AKT AND ERK VIA INTERFERENCE WITH N-LINKED GLYCOSYLATION, INDUCTION OF ENDOPLASMIC RETICULUM STRESS AND GSK-3β ACTIVATION

Por Kovács, Krisztina, Decatur, Christina, Toro, Marcela, Pham, Dien G., Liu, Huaping, Jing, Yuqi, Murray, Timothy G., Lampidis, Theodore J., Merchan, Jaime R.
Publicado no Mol Cancer Ther (2015)

Punctuated evolution of canonical genomic aberrations in uveal melanoma

Por Field, Matthew G., Durante, Michael A., Anbunathan, Hima, Cai, Louis Z., Decatur, Christina L., Bowcock, Anne M., Kurtenbach, Stefan, Harbour, J. William
Publicado no Nat Commun (2018)

BAP1 loss is associated with DNA methylomic repatterning in highly aggressive Class 2 uveal melanomas

Por Field, Matthew G., Kuznetsov, Jeffim N., Bussies, Parker L., Cai, Louie, Alawa, Karam A., Decatur, Christina L., Kurtenbach, Stefan, Harbour, J. William
Publicado no Clin Cancer Res (2019)

Retinoblastoma Treatment: Utilization of the Glycolytic Inhibitor, 2-deoxy-2-fluoro-d-glucose (2-FG), to Target the Chemoresistant Hypoxic Regions in LH(BETA)T(AG) Retinal Tumors

Por Piña, Yolanda, Decatur, Christina, Murray, Timothy G., Houston, Samuel K., Lopez-Cavalcante, Milena, Hernandez, Eleut, Celdran, Magda, Shah, Nikesh, Feuer, William, Lampidis, Theodore
Publicado em 2012

Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors

Por Piña, Yolanda, Houston, Samuel K, Murray, Timothy G, Koru-Sengul, Tulay, Decatur, Christina, Scott, William K, Nathanson, Lubov, Clarke, Jennifer, Lampidis, Theodore J
Publicado em 2012

Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations

Por Durante, Michael A., Walter, Scott D., Paez-Escamilla, Manuel, Tokarev, Julian, Decatur, Christina L., Dubovy, Sander R., Schefler, Amy C., Harbour, J. William
Publicado no JAMA Ophthalmol (2019)

PRAME as an independent biomarker for metastasis in uveal melanoma

Por Field, Matthew G., Decatur, Christina L., Kurtenbach, Stefan, Gezgin, Gülçin, van der Velden, Pieter A., Jager, Martine J., Kozak, Kaleigh N., Harbour, J. William
Publicado no Clin Cancer Res (2016)

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas

Por Field, Matthew G., Durante, Michael A., Decatur, Christina L., Tarlan, Bercin, Oelschlager, Kristen M., Stone, John F., Kuznetsov, Jeffim, Bowcock, Anne M., Kurtenbach, Stefan, Harbour, J. William
Publicado no Oncotarget (2016)

Single-cell analysis reveals new evolutionary complexity in uveal melanoma

Por Durante, Michael A., Rodriguez, Daniel A., Kurtenbach, Stefan, Kuznetsov, Jeffim N., Sanchez, Margaret I., Decatur, Christina L., Snyder, Helen, Feun, Lynn G., Livingstone, Alan S., Harbour, J. William
Publicado no Nat Commun (2020)

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis

Por Cavalcante, Ludimila L, Cavalcante, Milena L, Murray, Timothy G, Vigoda, Michael M, Piña, Yolanda, Decatur, Christina L, Davis, R Prince, Olmos, Lisa C, Schefler, Amy C, Parrott, Michael B, Alliman, Kyle J, Flynn, Harry W, Moshfeghi, Andrew A
Publicado em 2010